The following financial statement line items have been shown to reflect the adjustments recognized for each individual line item in the Company’s respective consolidated statements for the period noted:

Condensed Consolidated Statement of Profit or Loss and Comprehensive Loss


	Three months ended June 30, 2017 (As originally presented)			IFRS 15 Adoption		Three months ended June 30, 2017 Restated
	(euros in thousands)
Revenue		4,027			2,210		6,237
Operating result		(10,162	)		2,210		(7,952	)
Total comprehensive loss for the period		(21,798	)		2,210		(19,588	)
Basic (and diluted) loss per share		(1.12	)		0.11		(1.01	)


	Six months ended June 30, 2017 (As originally presented)			IFRS 15 Adoption		Six months ended June 30, 2017 Restated
	(euros in thousands)
Revenue		6,313			3,808		10,121
Operating result		(20,928	)		3,808		(17,120	)
Total comprehensive loss for the period		(43,114	)		3,808		(39,306	)
Basic (and diluted) loss per share		(2.27	)		0.20		(2.07	)

Condensed Consolidated Statement of Financial Position


	December 31, 2017 As originally presented			IFRS 15 Adoption			December 31, 2017 Restated
	(euros in thousands)
Accumulated loss		(167,480	)		8,705			(158,775	)
Deferred revenue, non-current		130,195			(17,644	)		112,551
Deferred revenue		6,996			8,939			15,935

Condensed Consolidated Statement of Cash Flows


	June 30, 2017 As originally presented			IFRS 15 Adoption			June 30, 2017 Restated
	(euros in thousands)
Result after taxation		(43,132	)		3,808			(39,324	)
Changes in working capital:
Deferred revenue		(3,091	)		(3,808	)		(6,899	)